glp-1 cardiovascular news JCI Results of cardiovascular outcomes trials
Description
The most common designs are observational studies
Gentle and effective for all ages
INTRODUCTION:While ubiquity of glucagon-like peptide receptor agonists (GLP1-RAs) is rising, guidance from the gastroenterology societies and...
We conducted a ...
A new class of drugs is reshaping global health,but Indias generics wave could change who benefits
This can improve metabolism and lead to better body composition
